Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Cervical Cancer

  Free Subscription

Articles published in Eur J Cancer

Retrieve available abstracts of 12 articles:
HTML format

Single Articles

    March 2024
  1. TUNINETTI V, Virano E, Salutari V, Ricotti A, et al
    Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
    Eur J Cancer. 2024;203:114039.
    PubMed     Abstract available

    February 2024
  2. TANAKA LF, Schoffer O, Schriefer D, Schauberger G, et al
    An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study.
    Eur J Cancer. 2024;201:113915.
    PubMed     Abstract available

    August 2023
  3. DING S, Li H
    Re: A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
    Eur J Cancer. 2023 Aug 1:112978. doi: 10.1016/j.ejca.2023.112978.

    February 2023
  4. WENZEL HHB, Hardie AN, Moncada-Torres A, Hogdall CK, et al
    A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
    Eur J Cancer. 2023;185:61-68.
    PubMed     Abstract available

    September 2022
  5. KREGTING LM, Olthof EMG, Breekveldt ECH, Aitken CA, et al
    Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
    Eur J Cancer. 2022;175:180-186.
    PubMed     Abstract available

    July 2022
  6. OAKNIN A, Monk BJ, Vergote I, Cristina de Melo A, et al
    EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
    Eur J Cancer. 2022 Jul 31. pii: S0959-8049(22)00160.
    PubMed     Abstract available

    October 2021
  7. CIBULA D, Dostalek L, Jarkovsky J, Mom CH, et al
    The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.
    Eur J Cancer. 2021;158:111-122.
    PubMed     Abstract available

    May 2021
  8. WENZEL HHB, Bekkers RLM, Lemmens VEPP, Van der Aa MA, et al
    No improvement in survival of older women with cervical cancer-A nationwide study.
    Eur J Cancer. 2021;151:159-167.
    PubMed     Abstract available

    March 2021
  9. MATHEVET P, Lecuru F, Uzan C, Boutitie F, et al
    Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2).
    Eur J Cancer. 2021;148:307-315.
    PubMed     Abstract available

  10. MATSUO K, Shimada M, Matsuzaki S, Enomoto T, et al
    Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic.
    Eur J Cancer. 2021;148:117-120.

    December 2020
  11. CIBULA D, Dostalek L, Hillemanns P, Scambia G, et al
    Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study.
    Eur J Cancer. 2020;143:88-100.
    PubMed     Abstract available

    September 2020
  12. MATSUO K, Huang Y, Matsuzaki S, Klar M, et al
    Effect of delay in surgical therapy for early-stage cervical cancer: An implication in the coronavirus pandemic.
    Eur J Cancer. 2020;139:173-176.

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.